Roivant Sciences ROIV
NASDAQ ROIV
$36.50 -0.48 (-1.30%)
At close: Sep 29, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Operating Margin (2020 - 2026)

Updated

Roivant Sciences (ROIV) reported Operating Margin of -25380.93% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 12250.88 percentage points from -13130.05% a year earlier and down 41858.71 percentage points from the prior quarter.

Analysis

Roivant Sciences (ROIV) Operating Margin (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Roivant Sciences' Operating Margin came in at -7914.75%, down 2810.02 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at -6235.69%, down 2782.37 percentage points from FY2025.

  • Operating Margin has a five-year change of -1735.17 percentage points (FY2021 to FY2026).
  • By fiscal year, Operating Margin came in at -3453.32% in FY2025 (-17200.25 pp), 13746.93% in FY2024 (+16622.80 pp), -2875.87% in FY2023 (-431.06 pp) and -2444.82% in FY2022 (+2055.70 pp).
  • The fiscal Q1 2027 figure ranks as the lowest quarterly Operating Margin in data going back to fiscal Q1 2021.
  • Year over year, Operating Margin gained in 1 of the last eight quarters, with an average year-over-year change of -8609.36 percentage points.
  • The high point for year-over-year Operating Margin in five years was fiscal Q3 2024 (a gain of 35165.76 percentage points); the low point was fiscal Q3 2025 (a drop of 35991.15 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at 16477.78% (Q4 2026), -16966.13% (Q3 2026) and -19492.87% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Roivant Sciences 26.72 Bn 27.41 Bn 1.16 Mn -25,380.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25,380.93%
Mar 31, 2026 16,477.78%
Dec 31, 2025 -16,966.13%
Sep 30, 2025 -19,492.87%
Jun 30, 2025 -13,130.05%
Mar 31, 2025 -3,764.40%
Dec 31, 2024 -3,042.59%
Sep 30, 2024 -7,636.04%
Jun 30, 2024 -1,279.54%
Mar 31, 2024 -2,293.06%
Dec 31, 2023 32,948.56%
Sep 30, 2023 -5,863.24%
Jun 30, 2023 -1,278.27%
Dec 31, 2022 -2,217.20%
Sep 30, 2022 -2,240.21%
Jun 30, 2022 -6,536.44%
Mar 31, 2022 -2,892.80%
Dec 31, 2021 -1,010.73%
Sep 30, 2021 -4,893.32%
Jun 30, 2021 -1,995.95%
API Access

Roivant Sciences Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ROIV&period=max&api_key=YOUR_API_KEY